The PBPK LeiCNS-PK3.0 framework predicts Nirmatrelvir (but not Remdesivir or Molnupiravir) to achieve effective concentrations against SARS-CoV-2 in human brain cells-Reference-Cited by-同舟云学术

The PBPK LeiCNS-PK3.0 framework predicts Nirmatrelvir (but not Remdesivir or Molnupiravir) to achieve effective concentrations against SARS-CoV-2 in human brain cells

Published:2023-02 Issue: Volume:181 Page:106345
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Saleh Mohammed A.A.^ORCID,Hirasawa Makoto,Sun Ming,Gülave Berfin,Elassaiss-Schaap Jeroen,de Lange Elizabeth C.M.^ORCID

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference52 articles.

1. Interaction cerveau-poumon;Abdennour;Ann. Fr. Anesth. Reanim.,2012

2. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier;Buzhdygan;Neurobiol. Dis.,2020

3. Global Incidence of Neurological Manifestations among Patients Hospitalized with COVID-19 - A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium;Chou;JAMA Netw. Open,2021

4. The pathophysiology of ‘happy’ hypoxemia in COVID-19;Dhont;Respir. Res.,2020

5. SARS-CoV-2 is associated with changes in brain structure in UK Biobank;Douaud;Nature,2022

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of MIDD to accelerate the development of anti-infectives: Current status and future perspectives;Advanced Drug Delivery Reviews;2024-09

2. In-vitro and in-vivo assessment of nirmatrelvir penetration into CSF, central nervous system cells, tissues, and peripheral blood mononuclear cells;Scientific Reports;2024-05-10

3. CNS Viral Infections—What to Consider for Improving Drug Treatment: A Plea for Using Mathematical Modeling Approaches;CNS Drugs;2024-04-05

4. The anti-COVID-19 drug Paxlovid crosses biological barriers of the placenta and brain in rats;npj Viruses;2024-01-24

5. Transporter modulation of molnupiravir and its metabolite β-D-N4-hydroxycytidine across the blood-brain barrier in a rat;Communications Medicine;2023-10-19